Global Markets for Medical Imaging Reagents and Analysis Equipment - Focus on Magnetic Resonance ImagingBCC ResearchJanuary 1, 2013 157 Pages - SKU: WA4925946 |
Additional Information
INTRODUCTIONSTUDY OBJECTIVES
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging technologies, which includes both the imaging systems and the contrast agents. The key objective is to present a comprehensive analysis and future direction of imaging techniques as an important tool for the usage in medical diagnostic procedures.
This report explores present and future strategies within the medical imaging technology market, which includes X-ray imaging, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. The improvisation of the market as well as the setbacks and needs of the market are discussed in this report. The classifications, comparisons, advantages and disadvantages and usage of these types of diagnostic methods are also listed in this report.
A detailed analysis of medical imaging industry structure has been conducted. Revenues are broken down by the region and sales figures are estimated for the five-year period from 2011 through 2017.
Applications for medical imaging technologies are also discussed separately in the report, with an emphasis of the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
Extensive research and new developments in the field of medical imaging technology has improved their usage in being able to be used as a prime diagnostic tool for various diseases and other medical conditions. Modern industries continue to explore the advantages of medical imaging technologies, leading to the steady market growth due to higher production of the imaging systems. This study is an update to the one published in January 2010.
R&D spending, along with increasing competition, new technologies, new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs.
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
This study contributes to the areas of market growth in medical imaging (imaging systems and contrast agents) product manufacturers and users. Pharmaceutical, biotechnical companies, research institutes, hospitals and physicians will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of imaging systems and contrast agents technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
- CHAPTER 1 INTRODUCTION
- STUDY OBJECTIVES
- REASONS FOR DOING THIS STUDY
- CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
- SCOPE OF THE STUDY
- METHODOLOGY
- INFORMATION SOURCES
- ABOUT THE AUTHOR
- RELATED BCC RESEARCH REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
- CHAPTER 2 SUMMARY
- SUMMARY TABLE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017 ($ MILLIONS)
- SUMMARY FIGURE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017 ($ MILLIONS)
- CHAPTER 3 OVERVIEW
- DEFINITIONS
- TYPES OF MEDICAL IMAGING
- X-RAY IMAGING
- History and Development of X-ray Imaging
- TABLE 1 HISTORY AND DEVELOPMENT OF X-RAY IMAGING
- Properties of X-ray
- Applications of X-ray in Medicine
- Advantages and Disadvantages of X-ray
- TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY
- ULTRASOUND
- History and Development of Ultrasound
- TABLE 3 HISTORY AND DEVELOPMENT OF ULTRASOUND
- Diagnostic Applications of Ultrasound
- Therapeutic Applications of Ultrasound
- Advantages and Disadvantages of Ultrasound
- TABLE 4 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND
- MAGNETIC RESONANCE IMAGING
- History and Development of Magnetic Resonance Imaging
- TABLE 5 HISTORY AND DEVELOPMENT OF MRI
- Applications of Magnetic Resonance Imaging
- Advantages and Disadvantages of MRI
- TABLE 6 ADVANTAGES AND DISADVANTAGES OF MRI
- COMPUTED TOMOGRAPHY
- Applications of Computed Tomography
- Advantages and Disadvantages of Computed Tomography
- TABLE 7 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY
- POSITRON EMISSION TOMOGRAPHY
- History and Development of Positron Emission Technology
- TABLE 8 HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY
- Advantages and Disadvantages of PET
- TABLE 9 ADVANTAGES AND DISADVANTAGES OF PET
- COMPARISON OF VARIOUS IMAGING MODALITIES
- TABLE 10 DIFFERENCES BETWEEN CT AND MRI
- TABLE 11 DIFFERENCES BETWEEN CT AND ULTRASOUND
- TABLE 12 DIFFERENCES BETWEEN CT AND PET
- TABLE 13 DIFFERENCES BETWEEN MRI AND X-RAY
- CONTRAST AGENTS
- PROPERTIES OF AN IDEAL CONTRAST AGENT
- UNDESIRABLE EFFECTS OF CONTRAST AGENTS
- Allergic Reactions
- Acute Renal Failure
- Aspiration
- Pulmonary Edema
- Seizure
- CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES
- Positive Contrast Agents
- Negative Contrast Agents
- CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING
- TECHNIQUE
- Contrast Agents for X-ray
- TABLE 14 ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM
- Contrast Agents for Magnetic Resonance Imaging
- Nonspecific Extracellular Agents
- TABLE 15 NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS
- Tissue-Specific Contrast Agents
- TABLE 16 LIVER-SPECIFIC CONTRAST AGENTS
- Contrast Agents for Ultrasound
- PET Radiopharmaceuticals
- TABLE 17 COMMONLY USED RADIOPHARMACEUTICALS
- IMAGING EQUIPMENT
- X-RAY IMAGING SYSTEM
- FLUOROSCOPY EQUIPMENT
- COMPUTED TOMOGRAPHY SCANNER
- Types of Computed Tomography Scanning
- Advances in CT Scanners /Types of CT Scanners
- ULTRASOUND MACHINES
- MAGNETIC RESONANCE IMAGING SYSTEM
- POSITRON EMISSION TOMOGRAPHY EQUIPMENT
- CHAPTER 4 REGULATORY ISSUES
- APPROVALS IN THE FIELD OF MEDICAL IMAGING
- NEW APPROVALS
- TABLE 18 NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012
- 510(K) APPROVALS
- TABLE 19 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008–AUGUST 2012
- TABLE 20 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012
- TABLE 21 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008–AUGUST 2012
- TABLE 22 510(K) APPROVALS FOR PET SYSTEMS, 2008–AUGUST 2012
- RECALLS
- TABLE 23 RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS
- TABLE 24 RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS, 2008—SEPTEMBER 2012
- TABLE 25 RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012
- TABLE 26 RECALLS FOR PET SYSTEMS, 2008—SEPTEMBER 2012
- APPROVALS FOR CONTRAST AGENTS
- TABLE 27 APPROVAL OF CONTRAST AGENTS
- SAFETY ALERTS
- TABLE 28 SAFETY ALERTS FOR CONTRAST AGENTS, 2008—SEPTEMBER 2012
- CHAPTER 5 NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS
- TABLE 29 NEW DEVELOPMENTS IN CONTRAST AGENTS
- TABLE 30 NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY
- TABLE 31 NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING
- TABLE 32 NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY
- TABLE 33 NEW DEVELOPMENTS IN ULTRASOUND
- TABLE 34 NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND FLUOROSCOPY)
- CHAPTER 6 GLOBAL MARKET ANALYSIS FOR IMAGING TECHNOLOGIES
- MARKET FOR CONTRAST AGENTS BY IMAGING TECHNOLOGY
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 35 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, THROUGH 2017 ($ MILLIONS)
- FIGURE 1 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2010–2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 36 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY 2011 (%)
- FIGURE 2 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2011 (%)
- MARKET FOR IMAGING SYSTEMS BY IMAGING TECHNOLOGY
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 37 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH 2017 ($ MILLIONS)
- FIGURE 3 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010–2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 38 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%)
- FIGURE 4 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%)
- GLOBAL MARKET FOR CONTRAST AGENTS BY REGION
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 39 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017 ($ MILLIONS)
- FIGURE 5 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010–2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 40 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%)
- FIGURE 6 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%)
- MARKET FOR IMAGING SYSTEMS BY REGION
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 41 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017 ($ MILLIONS)
- FIGURE 7 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010–2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 42 GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011 (%)
- FIGURE 8 GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011 (%)
- MARKET BY APPLICATIONS
- TABLE 43 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS)
- FIGURE 9 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010–2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 44 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%)
- FIGURE 10 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%)
- CHAPTER 7 MARKET ANALYSIS FOR MAGNETIC RESONANCE IMAGING
- MARKET FOR CONTRAST AGENTS BY REGION
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 45 GLOBAL MARKET FOR MRI AGENTS, BY REGION, THROUGH 2017 ($ MILLIONS)
- FIGURE 11 GLOBAL MARKET FOR MRI AGENTS, BY REGION, 2010-2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 46 MARKET SHARE OF MRI REAGENTS BY REGION, 2011 (%)
- FIGURE 12 MARKET SHARE OF MRI REAGENTS BY REGION, 2011 (%)
- MARKET FOR IMAGING SYSTEMS BY REGION
- MARKET OVERVIEW
- MARKET REVENUE
- TABLE 47 GLOBAL MARKET FOR MRI SYSTEMS, BY REGION, THROUGH 2017 ($ MILLIONS)
- FIGURE 13 GLOBAL MARKET FOR MRI SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 48 MARKET SHARE OF MRI SYSTEMS, BY REGION, 2011 (%)
- FIGURE 14 MARKET SHARE OF MRI SYSTEMS, BY REGION, 2011 (%)
- MARKET BY MAGNETIC STRENGTH
- MARKET REVENUE
- TABLE 49 GLOBAL MARKET FOR MRI SYSTEMS, BY MAGNETIC STRENGTH, THROUGH 2017 ($ MILLIONS)
- FIGURE 15 GLOBAL MARKET FOR MRI SYSTEMS, BY MAGNETIC STRENGTH, 2010-2017 ($ MILLIONS)
- MARKET BY APPLICATIONS
- TABLE 50 GLOBAL REVENUE FOR MRI REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS)
- FIGURE 16 GLOBAL REVENUE FOR MRI REAGENTS AND SYSTEMS USED FOR VARIOUS DISEASES, 2010-2017 ($ MILLIONS)
- MARKET SHARE
- TABLE 51 MAGNETIC RESONANCE IMAGING MARKET SHARES, BY APPLICATION, 2011 (%)
- FIGURE 17 MAGNETIC RESONANCE IMAGING MARKET SHARES, BY APPLICATION, 2011 (%)
- INDUSTRY STRUCTURE
- MAGNETIC RESONANCE IMAGING CONTRAST AGENTS
- Market Leaders
- TABLE 52 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST
- AGENTS
- Market Share
- TABLE 53 GLOBAL MARKET SHARES OF MRI CONTRAST AGENTS, 2011 (%)
- FIGURE 18 GLOBAL MARKET SHARES OF MRI CONTRAST AGENTS, 2011 (%)
- NUCLEAR MAGNETIC IMAGING SYSTEMS
- Market Leaders
- TABLE 54 LEADING MANUFACTURERS OF NUCLEAR MAGNETIC IMAGING SYSTEMS
- Market Share
- TABLE 55 GLOBAL MARKET SHARES OF MRI IMAGING SYSTEMS, 2011 (%)
- FIGURE 19 GLOBAL MARKET SHARES OF MRI IMAGING SYSTEMS, 2011 (%)
- CHAPTER 8 PATENT ANALYSIS
- CONTRAST AGENTS
- BY YEAR
- TABLE 56 TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008-JULY 2012
- BY IMAGING MODALITY
- TABLE 57 NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM 2008-JULY 2012
- BY COMPANY
- TABLE 58 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012
- BY COUNTRY
- TABLE 59 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012
- BY ASSIGNEE
- TABLE 60 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012
- IMAGING SYSTEMS
- BY YEAR
- TABLE 61 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012
- FIGURE 20 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012
- FIGURE 21 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008–JULY 2012 (%)
- BY IMAGING MODALITY
- TABLE 62 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012
- FIGURE 22 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012
- BY COMPANY
- TABLE 63 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012
- BY COUNTRY
- TABLE 64 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012
- FIGURE 23 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012
- BY ASSIGNEE
- TABLE 65 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012
- FIGURE 24 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012
- CHAPTER 9 DEMAND AND USE
- CONTRAST AGENTS MARKET
- REGULATORY ISSUES
- BABY BOOMER GENERATION
- INCREASING INCIDENCE OF LIFE-THREATENING DISEASES
- COMPETITION
- TECHNOLOGICAL ADVANCEMENTS
- SETBACKS IN INDUSTRY
- TRENDS IN THE IMAGING SYSTEMS MARKET
- CHAPTER 10 COMPANY PROFILES
- AMAG PHARMACEUTICALS INC.
- ANALOGIC CORPORATION
- BAYER HEALTHCARE PHARMACEUTICALS
- BRACCO IMAGING SPA
- COVIDIEN
- ECHOSON SA (PL)
- ESAOTE S.P.A
- FONAR CORPORATION
- GE HEALTHCARE
- GUERBET LLC
- HITACHI MEDICAL CORPORATION
- HOLOGIC INC
- LANTHEUS MEDICAL IMAGING
- MILLENIUM TECHNOLOGIES LTD.
- NORDION
- PARADIGM MEDICAL INDUSTRIES INC.
- PARAMED MEDICAL SYSTEMS INC.
- PHILIPS HEALTHCARE
- POSITRON CORPORATION
- SAMSUNG MEDISON AMERICA INC
- SHIMADZU CORPORATION
- SIEMENS AG
- SONOSITE INC
- TELEMED LTD.
- TERASON ULTRASOUND
- TIME MEDICAL INC.
- TOMTEC IMAGING SYSTEMS
- TOSHIBA MEDICAL SYSTEMS CORPORATIONS
- TRIAD ISOTOPES INC.
- ULTRASONIX MEDICAL CORP.
- VOLCANO CORPORATION
- ZONARE MEDICAL SYSTEMS INC.
- CHAPTER 11 APPENDIX I-ABBREVIATIONS
More NMR & MRI reports by BCC Research
Global Markets for Medical Imaging Reagents and Analysis Equipment by BCC Research
This report provides:
An overview of the medical imaging and diagnosing markets
Analyses of global market trends, with data from 2011, estimates for 2012, and ...
Emerging Diagnostic Technologies in the Changing U.S. Market by BCC Research
This report provides:
An overview of emerging diagnostic technologies, emphasizing the U.S. market in the context of efforts to rein in the cost of healthcare ...
Superconductors: Technologies and Global Markets by BCC Research
The global market for superconductivity applications was worth an estimated $1.7 billion in 2009, a figure that is expected to reach nearly $2 billion in ...
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets by BCC Research
See all reports like this >>In the U.S., recent reimbursement changes and the economic downturn have called the expanding use of MRI scanning into question. The North American market is ...
More Global NMR & MRI reports
Global Markets for Medical Imaging Reagents and Analysis Equipment by BCC Research
This report provides:
An overview of the medical imaging and diagnosing markets
Analyses of global market trends, with data from 2011, estimates for 2012, and ...
Pre-Clinical Imaging (In vivo) Market – By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017 by MarketsandMarkets
Pre-clinical imaging technologies are excellent tools for assessment of anatomical, physiological and functional parameters at molecular and cellular levels in the live animal models. It ...
Medical Image Analysis Software Market by Types, by Technology, by Image (2D, 3D & 4D) & by Indications - Global Trends, Opportunities & Forecast till 2017 by MarketsandMarkets
The growth of the medical image analysis market is mainly contributed by the standalone software market which is accelerating at a faster pace as compared ...
Proteomics Market (Protein Microarray, Mass Spectrometry, NMR, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) Instruments, Reagents & Services, Trends & Forecasts to 2017 by MarketsandMarkets
See all reports like this >>Proteomics, over the last decade, has gained importance in the field of diagnosis and drug research and development. It has various applications, ranging from identifying ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
NMR & MRI Reports
- Global Markets for Medical Imaging Reagents and Analysis Equipment
- Emerging Diagnostic Technologies in the Changing U.S. Market
- Pre-Clinical Imaging (In vivo) Market – By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
- Sweden Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
- Denmark Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others

